Endra Life Sciences Inc (NDRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Operating Expenses | 2,576 | 2,254 | 3,256 | 2,891 | 3,101 |
| Operating Income | -2,576 | -2,254 | -3,256 | -2,891 | -3,101 |
| Other Income | 307 | 4 | -3 | -3 | -222 |
| Pre-tax Income | -2,269 | -2,251 | -3,258 | -2,894 | -3,323 |
| Net Income Continuous | -2,269 | -2,251 | -3,258 | -2,894 | -3,323 |
| Net Income | $-2,269 | $-2,251 | $-3,258 | $-2,894 | $-3,323 |
| EPS Basic Total Ops | -2,097.90 | 349.65 | -5,244.76 | -6,993.01 | -10,139.86 |
| EPS Basic Continuous Ops | -2,100.58 | 367.63 | -4,768.46 | -6,866.47 | -10,094.86 |
| EPS Diluted Total Ops | -2,097.90 | 349.65 | -5,244.76 | -6,993.01 | -10,139.86 |
| EPS Diluted Continuous Ops | -2,100.58 | 367.63 | -4,768.46 | -6,866.47 | -10,094.86 |
| EBITDA(a) | $-2,527 | $-2,183 | $-3,238 | $-2,849 | $-2,835 |